Moxifloxacin-Induced Myasthenia GravisJessmer, Jill PharmD, BCPS*†; Topal, Jeffrey MD*‡Infectious Diseases in Clinical Practice: July 2013 - Volume 21 - Issue 4 - p 275–276 doi: 10.1097/IPC.0b013e318278f3d1 Case Reports Abstract Author Information Case reports describe exacerbation myasthenia gravis (MG) with fluoroquinolones in patients with and without a previous diagnosis of MG. Described is a case of moxifloxacin-induced MG in a patient with known MG. This is the first case report to describe moxifloxacin-induced MG and provide laboratory data supporting a drug-induced etiology. From the *Yale-New Haven Hospital, New Haven, CT; †Scripps Memorial Hospital, La Jolla CA; and ‡Yale University School of Medicine, New Haven, CT. Correspondence to: Jill Jessmer, PharmD, BCPS, Department of Pharmacy, Yale-New Haven Hospital, 55 Park St, New Haven, CT 06510. E-mail: firstname.lastname@example.org. The authors have no funding or conflicts of interest to disclose. © 2013 by Lippincott Williams & Wilkins.